Johnson & Johnson | 1Q 2025: Strong start to the year, but regional differences remain a challenge

The first quarter of 2025 delivered strong results for Johnson & Johnson across key areas. Profit growth, steady operational growth and advances in drug development signal that the company is well positioned for the rest of the year. While some segments face challenges, others show promising potential. What specifically is driving the current performance, where are new investments going, and how are investors responding?

What's happening?

Behind the scenes of the first quarter numbers, there is a clear shift in the company's strategy. Johnson & Johnson $JNJ is not only consolidating its strengths in pharmaceuticals and medical technology, but is also re-prioritizing toward innovation and new segments. Acquisitions in neurosciences and cardiology suggest that the company is purposefully expanding its reach beyond its traditional domains. The development of robotic solutions such as VELYS™ and OTTAVA indicates a drive to strengthen the technology side of care, while the consumer division…

Activate Bulios Black membership to access all analyses

The first 7 days are free!
Make stock selection easier with thorough analysis of top companies
Track the performance of your portfolio and dividends in the portfolio tracker
Get a detailed overview of the fair prices of thousands of popular companies
Improve your stock analysis with advanced artificial intelligence StockBot 1.0
Activate free
Don't have an account? Join us

Log in to Bulios


Or use email and password
Already a member? Log in

Create Bulios profile

Continue with

Or use email and password
You can use lowercase letters, numbers, and underscores

Why Bulios?

One of the fastest growing investor communities in Europe

Comprehensive data on thousands of stocks from around the world

Current information from global markets and individual companies

Education and exchange of investment experience among investors

Fair prices, portfolio tracker, stock screener and other tools

Menu StockBot
Tracker
Upgrade